This article has an accompanying continuing medical education activity, also eligible for MOC credit, on page e47. Learning Objective-Upon completion of this activity, successful learners will be able to identify the role of EGD in patients with uncomplicated gastroesophageal reflux disease, manage GERD in a patient without alarm symptoms with PPI, and identify the percentage of high-risk patients with uncomplicated GERD who undergo EGD.
S ymptoms of gastroesophageal reflux disease (GERD) affect more than 25% of adults living in the United States. 1 Although GERD is a risk factor for developing Barrett's esophagus (BE), the prevalence of BE in patients with GERD symptoms who do not have dysphagia is uncertain. The prevalence of BE in the proton pump inhibitor (PPI) era is also uncertain. In prior studies of patients with chronic GERD symptoms, 3%-8% have long-segment (3 cm) BE, and 10%-15% of these patients have short-segment BE, in comparison with an estimated overall prevalence of 1.6%-5.6% of BE of any length in the general population without reported GERD symptoms. [2] [3] [4] [5] [6] The role of upper gastrointestinal esophagogastroduodenoscopy (EGD) in the evaluation of GERD remains uncertain in the absence of alarm symptoms.
The American Gastroenterological Association (AGA) strongly recommends against screening the general population with GERD for BE. The AGA also weakly recommends for screening patients with multiple risk factors associated with esophageal adenocarcinoma (EAC) (age >50, male gender, white race, chronic GERD, hiatal hernia, elevated body mass index, intra-abdominal distribution of body fat), although it is not clear how much weight to place on each of these factors. 7 In clinical practice, EGD is often used to evaluate GERD. Patients with concomitant alarm symptoms, such as dysphagia, weight loss, and bleeding, have clear indications for endoscopy regardless of the presence or absence of GERD. However, the benefit of using EGD for the evaluation of uncomplicated GERD in clinical practice is not known. Although our group has previously reported on the prevalence of GERD and BE across race, age, and gender, these studies largely preceded the widespread use of PPI, which became available over the counter in 2003. 8, 9 We hypothesize that the use and outcomes of EGD for evaluation of uncomplicated GERD in the United States have changed over the period of [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] .
The primary aims of this analysis were to determine prevalence of GERD without alarm symptoms as an indication for EGD; and demographic characteristics and endoscopic outcomes in this population. The secondary aims of this analysis were to determine whether there is an association between patient demographics and likelihood of BE; and whether particular endoscopic findings, such as hiatal hernia or active esophagitis, increase the likelihood of BE.
Methods

Clinical Outcomes Research Initiative
This project was developed in 1995, creating a consortium of clinical practice settings to determine use and outcomes of endoscopic procedures. Participating endoscopists use a structured computerized endoscopic report generator to produce endoscopic reports. The data that are transmitted from the local site to the National Endoscopic Database do not contain most patient or provider identifiers and qualify as a Limited Data Set under 45 C.F.R. Section 164.514(e). 8 After completion of quality control checks, data from all sites are merged in the data repository for analysis. Procedure counts are monitored on a weekly basis for atypical activity.
Practice Sites
Complete EGD reports received between January 1, 2003, and December 31, 2014, were included. The reports come from 82 practices. We have conducted several analyses to determine the representativeness of our data. We previously reported comparison of CMS data with the cohort of Clinical Outcomes Research Initiative (CORI) subjects age 65 and older, demonstrating that the CORI cohort is representative of US endoscopy practice in this age group. 10 
Patient Groups
Patients 18 years or older are included. Demographic characteristics of patients include age, sex, race, and ethnicity. Race was recorded as white non-Hispanic (white), black non-Hispanic (black), Hispanic, Asian, or other. This analysis includes only the first examination for each patient during the study period. The endoscopist selected a procedure indication from a standard list available in CORI. The primary study group was defined as patients undergoing EGD with a primary indication of "reflux symptoms," and allowing only secondary indications of "abdominal pain" and "dyspepsia."
Endoscopic Endpoints
A key endpoint is suspected BE (sBE). Those with sBE of 3 cm were classified as suspected short-segment BE. Those with sBE 3 cm were classified as suspected longsegment BE (sLSBE). The diagnosis of true BE depends on histologic confirmation of intestinal metaplasia from biopsies in the tubular esophagus. Our prior work has shown that about 50% patients with sBE do not have biopsy-confirmed intestinal metaplasia, with longer segments of sBE being significantly more likely to have BE confirmed on histology. 11 This could be caused by the absence of intestinal metaplasia or inadequate biopsies. We acknowledge that there may be misclassification of BE using endoscopic criteria alone. However, clinical decisions to obtain biopsies or perform follow-up examinations are often based on the endoscopic appearance of the esophagus.
Other endoscopic outcomes recorded include presence of hiatal hernia, esophagitis, gastric ulcers, duodenal ulcers,
What You Need to Know
Background EGDs are frequently used to evaluate GERD without alarm symptoms, although the benefits are not clear.
Findings
In an analysis of a large cohort of patients undergoing EGD, uncomplicated GERD accounted for almost 14% of EGDs. Within this population, only 5.6% had suspected Barrett's esophagus of any length, and an estimated 1.4% had suspected Barrett's esophagus 3 cm. Only 23.6% of EGDs for uncomplicated GERD were performed in white men older than 50 years.
Implications for patient care
The prevalence of suspected Barrett's esophagus is lower than in prior time periods. This raises questions about the utility of EGDs to detect Barrett's esophagus in patients with uncomplicated GERD. and tumors. Depending on the user, esophagitis was graded either on a scale of mild, moderate, or severe; or as Los Angeles (LA) grade A, B, C, or D. 12 For purposes of analysis, the grades were grouped as follows: mild/LA grade A, moderate/LA grade B, and severe/LA grade C or D.
Analysis
The analysis considered the entire time period of 2003-2014. Analyses included the relationships between patient demographics and endoscopic findings; and relationships between findings of hiatal hernia and esophagitis with sBE.
Comparison of categorical data was performed by using Pearson chi-square test. Analysis of variance was performed to compare continuous variables. Univariate logistic regression analyses were performed to generate odds ratios (ORs) for the outcomes of sBE and ulcer by age, gender, and race/ethnicity. The models were limited to patients of white, black, Hispanic, and Asian race/ ethnicity because of small sample sizes for the remaining race/ethnic groups. All analyses were performed with version 9.4 of SAS software (SAS Institute Inc, Cary, NC).
Results
From 2003 to 2014, initial EGDs were performed on 543,103 patients. Of these, 73,535 (13.5%) were performed for a primary indication of uncomplicated GERD (Table 1) . Most were performed at community practices (79.3%), with the remainder at academic centers (10.2%) and Veterans Affairs medical centers (10.5%). The mean age was 53.1 years, with 38% of patients <50 years old. This population was 48% male and 81% whites. sBE was found in 4122 (5.6%) patients with uncomplicated GERD (Table 2) . Of these 4122 patients with sBE, 3159 (76.7%) had length recorded; 772 patients met criteria for sLSBE. Reflux esophagitis was found in 15,969 (21.7%) patients, with 9.2% of these cases classified as severe or LA class C/D. A hiatal hernia was recorded in 31,489 (42.8%) patients.
Endoscopic findings were stratified by gender (Table 3) , age (Table 4) , and ethnicity (Table 5 ). Adjusted ORs relative to patients without sBE are shown in Table 6 . sBE was significantly more common in men compared with women (8.1% vs 3.3%; OR, 2.61; 95% confidence interval [CI], 2.44-2.79). The prevalence increased with age from 4.0% in patients <40 years to 6.3% in patients older than 60 years. White persons were more likely to have BE compared with all other races (6.1% vs 2.1%; OR, 1.81; 95% CI, 1.65-2.00). Among those with length of BE There were 104 tumors described in 101 patients. Of these, there were 47 esophageal tumors, 42 gastric tumors, 13 duodenal tumors, 1 tumor in the palate, and 1 patient did not have a specific tumor location recorded. Of the 47 patients with esophageal tumors, there were 39 (83.0%) men, 42 (89.4%) had age >50 years, and 41 (87.2%) were white. Of the 41 patients with gastric tumors, 20 (48.8%) were men, 31 (75.6%) had age >50 years, and 24 (58.5%) were white. Thirty-four of these patients were white, male, and had age >50 years. Of the 13 patients with duodenal 
Discussion
This is the largest analysis of upper endoscopy practice for uncomplicated GERD that has ever been reported from nonclaims data sources in the United States, and shows that EGDs done for a primary indication of uncomplicated GERD account for more than 10% of all EGDs annually. In this population, 5.6% patients had sBE and an estimated 1.4% patients had sLSBE. Male gender, white race, and advancing age were associated with both increased sBE and sLSBE. Severe esophagitis was found in an estimated 2% patients and ulcers were found in 1.8% patients, whereas tumors were rare.
Although the demographics largely mirrored that of patients undergoing EGD for other reasons in the CORI database, 1 notable exception is that the percentage of patients <50 years old undergoing EGDs was actually higher in this subset of patients undergoing EGD for uncomplicated GERD. Despite the AGA recommendation to focus screening on patients with multiple risks of adenocarcinoma, namely white males age >50 years, it is notable that most EGD-GERD are performed in women, 38% of EGDs are performed before age 50, and 25% performed in nonwhites. Only 23.6% patients met all 3 of the criteria of the AGA recommendation.
Among this group of patients undergoing EGD for uncomplicated GERD, the most common findings were esophagitis (21.7%) and hiatal hernias (43%). North American studies from the late 1990s to early 2000s described rates of esophagitis from 34% to 56% in patients undergoing EGD for uncomplicated GERD. 13, 14 The lower percentage of patients with esophagitis in our cohort may speak to the efficacy of acid reflux treatment among patients who receive endoscopy in the PPI era. 15 Patients with uncomplicated GERD and esophagitis can often be treated empirically, and may not necessarily benefit from EGD. Findings of notable pathology that warrant further management were found on 9.5% of EGDs in patients with uncomplicated GERD, with most of these being sBE (5.6%); other findings included severe or LA grade C/D esophagitis (2%), gastric or duodenal ulcers (1.8%), and suspected tumors (<0.1%). The rate of sLSBE in our study is a little more difficult to calculate. Assuming the percentage of sLSBE remained consistent for those with unknown length of sBE, 1.4% of all patients undergoing EGD for uncomplicated GERD have sLSBE, with a range from 1.0% (none of the unknown lengths were sLSBE) to 2.4% (all of the unknown lengths were sLSBE). The true rates of BE (based on histology) in our study are likely lower than the rates of sBE, based on our prior work. 11 These rates of both sBE (5.6%) and sLSBE (1.4%) are lower than prior estimates of BE in GERD patients. Studies from the 1970s and 1980s suggested rates of BE in patients with GERD symptoms ranging from 8.2% to 12.4%. 3, 16, 17 Many of these studies included patients with dysphagia or abnormal imaging, which could have inflated the rates of BE. Studies from the late 1990s to early 2000s in patients with GERD symptoms found rates of BE ranging from 8.3% to 13.2%, and rates of LSBE ranging from 2.6% to 4.8%. 4, 5, 18 Lower rates of sBE in the current study could reflect the inclusion of patients with alarm symptoms in prior studies and changes in use of EGD for GERD. Since the mid-1990s, EGD has often been used to screen patients with GERD for BE, with or without alarm symptoms. It is also possible that there is a true decline in rates of BE, over the past 20-30 years. However, because obesity is a risk factor for GERD and BE, we might have otherwise expected an increased, not a decreased rate of BE. Our finding of lower rates of BE coincides with increased prevalence of PPI use, which may have prevented the onset of BE in some patients. Our data support the hypothesis that rates of BE from 2003 to 2014 are lower than previously described in patients who have uncomplicated GERD. As shown by prior studies, age >50 years (OR, 1.34; 95% CI, 1.25-1.44), male gender (OR, 2.61; 95% CI, 2.44-2.79), and white race (OR, 1.81; 95% CI, 1.65-2.00) were strongly associated with increased risk of sBE. 8, [20] [21] [22] However, the absolute risk for these patient groups remains relatively low, with the following respective rates: age >50 (sBE 6.1%, LSBE 1.7%), male gender (sBE 8.1%, LSBE 2.2%), white race (sBE 6.1%, LSBE 1.5%). In the highest risk cohort of white men with age >50, prevalence of sBE was 9.8%% (number needed to screen, 10) and sLSBE was 1.4% (number needed to screen, range 23-43). It has previously been shown in a model that screening for BE in white men age >50 with GERD symptoms is likely cost-effective, although the model assumed a prevalence of 10% of BE in this population. 23 Our prevalence of histologically proven sBE would fall far short of this threshold. Given the even lower prevalence of sBE in women (3.3%), age <50 (4.6%), and nonwhite patients (4.5%), the value of endoscopy in these low-risk populations is particularly limited. If EGDs were limited to patients that met the AGA criteria of being male, white, and age >50, we would have detected 34 of 47 (72.3%) of esophageal tumors and finding sBE in nearly 10%, whereas reducing the burden of endoscopy by more than 75%.
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The presence of a hiatal hernia was strongly associated with sBE (OR, 1.6; 95% CI, 1.5-1.7) and LSBE (OR, 1.86; 95% CI, 1.57-2.21). Although the presence of esophagitis was not associated with sBE, it was associated with the presence of sLSBE. It is possible that part of the lack of association is caused by esophagitis masking underlying BE, which is more commonly short-segment in nature. 24 Severe or grade C/D esophagitis was still strongly associated with both sBE and sLSBE. We suspect that many patients with uncomplicated GERD received some antisecretory therapy before having EGD, and that patients with suspected short-segment BE may have milder forms of esophagitis or disease that is better controlled with medical treatment, compared with individuals with sLSBE.
Chronic GERD can cause BE, which can lead to EAC. 25 The incidence of EAC has steadily risen since the 1970s, initially increasing at a rate of 8% per year until the late 1990s, then slowing to a rate of increase of less than 2% per year since then, with an incidence of 2.8 per 100,000 in 2012. 26, 27 Hypotheses for this deceleration of EAC risk include decline in smoking, better management of GERD, or surveillance of BE. Because many patients with EAC do not have GERD symptoms, screening patients with GERD can only have a limited effect. 28, 29 Among patients with BE, the estimated annual incidence of EAC is only 0.1%-0.4% per year and the estimated mortality from EAC is 3 per 1000 person-years. [30] [31] [32] [33] The prevalence of ulcers in patients with uncomplicated GERD symptoms is not uncommon (1.8%), which may reflect some overlap of symptoms of GERD and dyspepsia. The demographic risk factors for ulcers are different than for sBE. Although age >50 was also associated with increased risk of ulcers (OR, 1.43; 95% CI, 1.27-1.60), there was no difference in ulcer rates between men and women, and white patients were at lower risk compared to nonwhite patients (OR, 0.68; 95% CI, 0.60-0.77).
Tumors were a very rare finding (0.1%) and shared similar risk factors with BE, namely male gender, increased age, and white race, with the exception of gastric tumors, which were evenly split between male and female patients. This raises questions about the role of biology and genetic differences in the development of different types of upper gastrointestinal pathology.
Study Limitations
The CORI database provides snapshots of endoscopic practice that depend on data provided in the endoscopic report. We believe these data are as accurate as possible because they become part of the official medical record and are used for quality assurance purposes. Misclassification of race or ethnicity is possible, because the endoscopist or nurse provided this information.
Procedure indications are provided by the endoscopists. In patients with multiple reasons for examination, some misclassification is possible. Key outcomes data are adjusted for age, gender, and race to reduce the likelihood that practice changes may have altered the key outcomes. The selection of sBE and suspected malignancy as study endpoints is discussed in the Methods section. We acknowledge that many patients with sBE do not have histologically proven BE. Our prior work suggests that about 40% of patients with suspected short-segment BE and 75% of sLSBE have histologic intestinal metaplasia consistent with BE.
11 Therefore, we believe that the detection of sBE overestimates the true prevalence of BE in this population. Certain findings, such as hiatal hernia and esophagitis, may be underreported in patients who have other findings, such as sBE or ulcer.
Conclusions
We report on data from more than 70,000 EGDs performed in diverse clinical practices for GERD without alarm symptoms. This accounted for 13.5% of all EGDs done during this time period and reflects a significant cost to the health care system. This is the largest report of EGD outcomes in the post-PPI era. In the absence of alarm symptoms, it is likely that most EGDs were performed to determine the presence or absence of BE.
Our study confirms previously suggested risk factors of older age, male gender, and white ethnicity for sBE and sLSBE. We find that low-risk populations with uncomplicated GERD make up a significant number of EGDs done for uncomplicated GERD, with white men, age >50 comprising only 23.6% of this cohort.
Our study also demonstrates a lower prevalence of sBE and sLSBE compared with prior studies, which raises questions about the utility of EGDs to assess for BE in any population with uncomplicated GERD. In the absence of alarm
